Holen Sie sich die Stockscreener-App
20.41
0.68%
-0.14
Schlusskurs vom Vortag:
$20.55
Offen:
$20.79
24-Stunden-Volumen:
187.86K
Relative Volume:
0.62
Marktkapitalisierung:
$964.83M
Einnahmen:
$502.79M
Nettoeinkommen (Verlust:
$23.71M
KGV:
40.82
EPS:
0.5
Netto-Cashflow:
$6.35M
1W Leistung:
+0.49%
1M Leistung:
+5.04%
6M Leistung:
+13.90%
1J Leistung:
+10.26%
1-Tages-Spanne:
$20.33
$21.00
1-Wochen-Bereich:
$20.20
$21.77
52-Wochen-Spanne:
$13.82
$25.13
Core Laboratories Inc Stock (CLB) Company Profile
Firmenname
Core Laboratories Inc
Sektor
Telefon
713-328-2673
Adresse
6316 WINDFERN ROAD, HOUSTON
Vergleichen Sie CLB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLB
Core Laboratories Inc
|
20.41 | 964.83M | 502.79M | 23.71M | 6.35M | 0.50 |
|
SLB
Schlumberger Ltd
|
43.66 | 62.49B | 36.00B | 4.48B | 5.15B | 2.89 |
|
BKR
Baker Hughes Company
|
43.61 | 43.07B | 27.30B | 2.24B | 1.79B | 1.66 |
|
HAL
Halliburton Co
|
31.88 | 28.07B | 23.07B | 2.55B | 2.40B | 2.91 |
|
TS
Tenaris S A Adr
|
38.09 | 21.56B | 13.09B | 2.65B | 2.52B | 6.10 |
|
FTI
Technipfmc Plc
|
31.01 | 13.20B | 8.79B | 671.20M | 856.30M | -0.0791 |
Core Laboratories Inc Stock (CLB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-06-30 | Herabstufung | Citigroup | Neutral → Sell |
| 2023-04-18 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-01-09 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-10-07 | Hochstufung | Citigroup | Sell → Neutral |
| 2022-09-26 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2022-04-18 | Herabstufung | Piper Sandler | Neutral → Underweight |
| 2021-10-18 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-07-09 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-06-14 | Herabstufung | Citigroup | Neutral → Sell |
| 2020-12-18 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-11-11 | Bestätigt | Cowen | Market Perform |
| 2020-10-13 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2020-09-29 | Hochstufung | ABN Amro | Sell → Hold |
| 2020-07-16 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2020-04-13 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2020-03-09 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2020-03-09 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2020-01-31 | Bestätigt | Cowen | Market Perform |
| 2020-01-30 | Fortgesetzt | Johnson Rice | Buy |
| 2020-01-14 | Eingeleitet | Bernstein | Mkt Perform |
| 2020-01-02 | Herabstufung | Stifel | Buy → Hold |
| 2019-12-31 | Bestätigt | Cowen | Market Perform |
| 2019-07-10 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-02-25 | Hochstufung | Tudor Pickering | Hold → Buy |
| 2018-12-19 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2018-12-11 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2018-11-16 | Hochstufung | Guggenheim | Neutral → Buy |
| 2018-11-01 | Hochstufung | ABN Amro | Sell → Buy |
| 2018-10-29 | Bestätigt | Cowen | Market Perform |
Alle ansehen
Core Laboratories Inc Aktie (CLB) Neueste Nachrichten
Core Laboratories (FRA:HJ1) Earnings Yield % : 2.56% (As of Nov. 27, 2024) - GuruFocus.com
Core Laboratories (FRA:HJ1) Future 3-5Y EPS without NRI Gro - GuruFocus.com
Core Laboratories (FRA:HJ1) Cash Flow from Operations : €50.6 Mil (TTM As of Sep. 2024) - GuruFocus.com
Core Laboratories (FRA:HJ1) Free Cash Flow per Share : €0.85 (TTM As of Sep. 2024) - GuruFocus.com
Core Laboratories (FRA:HJ1) EPS without NRI : €0.65 (TTM As of Sep. 2024) - GuruFocus.com
Core Laboratories (FRA:HJ1) EBITDA per Share : €1.42 (TTM As of Sep. 2024) - GuruFocus.com
Core Laboratories (FRA:HJ1) Operating Income : €48.9 Mil (TTM As of Sep. 2024) - GuruFocus.com
Core Laboratories (FRA:HJ1) Cyclically Adjusted PB Ratio : 6.41 (As of Nov. 26, 2024) - GuruFocus.com
Core Laboratories (FRA:HJ1) Total Inventories : €59.0 Mil (As of Sep. 2024) - GuruFocus.com
Eagle Asset Management Inc. Makes New $3.53 Million Investment in Core Laboratories Inc. (NYSE:CLB) - MarketBeat
Oppenheimer & Co. Inc. Reduces Stock Position in Core Laboratories Inc. (NYSE:CLB) - Defense World
Why Is Core Laboratories (CLB) Up 11.5% Since Last Earnings Report? - Yahoo Finance
Core Laboratories (STU:HJ1) Profitability Rank : 7 (As of Sep. 2024) - GuruFocus.com
Principal Financial Group Inc. Has $4.12 Million Position in Core Laboratories Inc. (NYSE:CLB) - Defense World
Core Laboratories Inc (CLB) Stock Price Up 4.78% on Nov 21 - GuruFocus.com
GSA Capital Partners LLP Makes New Investment in Core Laboratories Inc. (NYSE:CLB) - Defense World
Core Laboratories (FRA:HJ1) Price-to-Operating-Cash-Flow : 17.50 (As of Nov. 20, 2024) - GuruFocus.com
Core Laboratories Beats Analyst Estimates on EPS - AOL
Royce & Associates LP Has $18.92 Million Holdings in Core Laboratories Inc. (NYSE:CLB) - MarketBeat
US Bancorp DE Sells 572 Shares of Core Laboratories Inc. (NYSE:CLB) - Defense World
Core Laboratories (FRA:HJ1) 3-Year EPS without NRI Growth R - GuruFocus.com
Calculating The Fair Value Of Core Laboratories Inc. (NYSE:CLB) - Yahoo Finance
Is Core Laboratories (NYSE:CLB) Using Too Much Debt? - Simply Wall St
Van ECK Associates Corp Has $7.13 Million Stock Holdings in Core Laboratories Inc. (NYSE:CLB) - MarketBeat
Is the Options Market Predicting a Spike in CORE LABS INC (CLB) Stock? - Yahoo Finance
Core Laboratories (NYSE:CLB) Upgraded by StockNews.com to "Hold" Rating - MarketBeat
Core Laboratories (NYSE:CLB) Upgraded to Hold at StockNews.com - Defense World
Citigroup Issues Pessimistic Forecast for Core Laboratories (NYSE:CLB) Stock Price - Defense World
Core Laboratories Inc. (NYSE:CLB) Receives $18.00 Average Target Price from Analysts - Defense World
Core Laboratories Inc. (NYSE:CLB) Holdings Cut by Creative Planning - Defense World
StockNews.com Upgrades Core Laboratories (NYSE:CLB) to Hold - Defense World
Core Laboratories (NYSE:CLB) Upgraded by StockNews.com to Hold - MarketBeat
Core Laboratories (NYSE:CLB) Shares Gap DownTime to Sell? - MarketBeat
Core Laboratories Inc. (NYSE:CLB) Stake Reduced by Boston Trust Walden Corp - MarketBeat
Core Laboratories N.V. (NYSE:CLB) Q3 2024 Earnings Call Transcript - Insider Monkey
Core Laboratories Third Quarter 2024 Earnings: EPS Beats Expectations - Yahoo Finance
Core Laboratories' Q3 Earnings and Sales Beat Estimates - MSN
Core Laboratories Inc (CLB) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ... - Yahoo Finance
Core Laboratories Inc (CLB) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ... By GuruFocus - Investing.com Canada
Core Laboratories (NYSE:CLB) Shares Gap Up Following Better-Than-Expected Earnings - Defense World
Core Laboratories Inc. Declares Quarterly Dividend of $0.01 (NYSE:CLB) - MarketBeat
Core Laboratories (CLB) Q3 2024 Earnings Call Transcript - AOL
Earnings call: Core Laboratories reports steady growth in Q3 2024 By Investing.com - Investing.com Canada
Core Laboratories (NYSE:CLB) Issues Quarterly Earnings Results - MarketBeat
Core Laboratories (NYSE:CLB) Shares Gap Up on Better-Than-Expected Earnings - MarketBeat
Core Laboratories Q3 2024 Earnings Preview - MSN
Core Laboratories: Q3 Earnings Snapshot - The Washington Post
Core Laboratories (NYSE:CLB) Issues Q4 Earnings Guidance - MarketBeat
Core Laboratories (CLB) Q3 Earnings Match Estimates - Yahoo Finance
CORE LAB REPORTS THIRD QUARTER 2024 RESULTS - PR Newswire
Core Laboratories Inc (CLB) Q3 2024 Earnings: EPS of $0.25 Beats Estimates, Revenue Hits $134.4 Million - GuruFocus.com
Finanzdaten der Core Laboratories Inc-Aktie (CLB)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.27%
0.52%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):